Related Experiment Video
Updated: Jul 17, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
SIRT5/7 desuccinylation in cancer: linking metabolism, immunity, and drug resistance
1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Abstract:
The sirtuin family proteins SIRT5 and SIRT7, as NAD⁺-dependent lysine desuccinylases, exert critical yet context-dependent roles in cancer progression. Mitochondrial SIRT5 functions as a metabolic rheostat, desuccinylating key enzymes in the TCA cycle, glutaminolysis, and fatty acid oxidation to maintain redox balance and bioenergetic output. Conversely, nuclear SIRT7 acts as an epigenetic modulator, regulating chromatin architecture and DNA damage repair via histone and non-histone desuccinylation. These compartmentalized activities converge to coordinate a metabolic-epigenetic axis that drives tumor adaptation to metabolic stress, evasion of immune surveillance, and therapeutic resistance. Given this functional duality, biomarker-guided therapeutic strategies are imperative. This review synthesizes the emerging roles of SIRT5/7-mediated desuccinylation in cancer metabolism, immunity, and drug resistance, highlighting their potential as targets for synergistic metabolic-immunotherapy interventions.
Insights
Sirtuin proteins SIRT5 and SIRT7 regulate cancer progression by desuccinylating key metabolic and epigenetic targets. Understanding their dual roles is crucial for developing targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Biology
Background:
- Sirtuins (SIRTs) are NAD⁺-dependent enzymes involved in cellular metabolism and epigenetics.
- SIRT5 and SIRT7, specific sirtuin family members, play critical roles in cancer progression.
- These proteins function as lysine desuccinylases, modifying key cellular targets.
Purpose of the Study:
- To review the emerging roles of SIRT5 and SIRT7-mediated desuccinylation in cancer.
- To highlight their involvement in cancer metabolism, immune evasion, and therapeutic resistance.
- To explore their potential as targets for novel cancer therapies.
Main Methods:
- Literature review synthesizing current research on SIRT5 and SIRT7 in cancer.
- Analysis of the desuccinylation activities of SIRT5 and SIRT7 in different cellular compartments.
- Integration of metabolic and epigenetic roles of SIRT5/7 in tumor adaptation.
Main Results:
- Mitochondrial SIRT5 desuccinylates metabolic enzymes, maintaining redox balance and energy production.
- Nuclear SIRT7 desuccinylates histones and non-histone proteins, regulating chromatin and DNA repair.
- The combined actions of SIRT5 and SIRT7 establish a metabolic-epigenetic axis promoting tumor survival and resistance.
Conclusions:
- SIRT5 and SIRT7 exhibit distinct yet coordinated functions in cancer progression.
- Their roles in metabolic adaptation, immune evasion, and drug resistance make them promising therapeutic targets.
- Biomarker-guided strategies targeting the SIRT5/7-mediated desuccinylation pathway could lead to effective metabolic-immunotherapy interventions.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Sulfur Assimilation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Treatment Resistant Cancers